NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 60.28

+6.3%

11:50 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocky9 who wrote (30)	2/16/2006 1:07:20 PM
From: tuck	Read Replies (1) of 507

Interesting discussion of Exubera's prospects in the link below. There seems to be a disconnect between what patients want and what insurers want, given the expected high cost versus SC insulin. Until that is resolved, I'd say this is a middling product. As I've said before, slow, steady uptake -- unless and until insurers are really on board. pipeline.corante.com Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next